Francis Medical Announces Close of Record $80 Million Series C Equity Financing
Funding will continue supporting VAPOR 2 pivotal clinical study and U.S. commercialization of Vanquish Water Vapor Ablation proprietary prostate cancer treatment MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ — Francis Medical, Inc., a privately-held medical device company developing an innovative and…
